Claus Dahl
Papers
1
Total Citations
7
H-Index
1
About
Claus Dahl is a distinguished urologic surgeon and researcher whose work focuses on advancing surgical techniques for upper tract urothelial carcinoma. His primary research areas include minimally invasive nephroureterectomy, lymphadenectomy outcomes, and robotic-assisted urologic oncology. Dahl’s most cited study, "Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?" (2017, 7 citations), critically evaluates the role of lymph node dissection in improving patient prognosis. This work contributes to ongoing debates about the oncological benefits of extended lymphadenectomy, offering evidence that helps refine surgical guidelines. Beyond this key paper, Dahl’s broader portfolio addresses perioperative outcomes and quality-of-life metrics in urologic cancer care. While his citation count reflects a focused, emerging impact, his research is valued for its direct clinical relevance, particularly in standardizing approaches to high-risk upper tract disease. Dahl’s contributions are notable for bridging laparoscopic and robotic modalities, emphasizing evidence-based decision-making in complex surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1